Pharmacognosy Research logo
Article

Biological and Chemical Study of Cleome paradoxa B.Br.

1, 2, 3

  1. 1Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.
  2. 2Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
  3. 3Pharmacology Department, National Research Centre, Giza 12622, Egypt.

CORRESPONDENCE

Essam Abdel-Sattar

Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.

abdelsattar@yahoo.com

Received: 14-04-2009; Accepted: 02-06-2009.

Volume 1, Issue 4 · pp. 175-178 · 2009 · DOI:

ABSTRACT

The methanolic extract of Cleome paradoxa B.Br. and its different fractions (viz. hexane, chloroform, ethyl acetate and n-butanol) were tested for their antidiabetic activities. The ethyl acetate and hexane fractions exhibited the highest activities, which further subjected to chemical investigation. This study resulted in isolation of two compounds from the ethyl acetate fraction and three compounds from the hexane fraction. These compounds were identified using different spectroscopic methods as quercetin, quercetin-3-O-β-D-glucopyranoside (isoquercetrin), α-amyrin, sitgmasterol and sitgmasterol-3-O-β-D-glucpyranoside. The major compound isolated from ethyl acetate fraction, isoquercetrin, was assessed for its antidiabetic activity.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Abdel-Sattar, E., El-Monem, A. R. A., & Sleem, A. A. (2009). Biological and Chemical Study of Cleome paradoxa B.Br.. Pharmacognosy Research, 1(4), 175-178.

    Copyright and licence

    © 2009 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0